Trials / Completed
CompletedNCT05186662
Comparing the Efficacy of WeChat-based Patient Education and Conventional Patient Education in the Management of Helicobacter Pylori Eradication
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,017 (actual)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
we conducted a retrospective study to compare the efficacy of WeChat-based patient education and conventional patient education in the management of Helicobacter pylori eradication.
Detailed description
This is a single-institute retrospective study comparing the efficacy of WeChat-based patient education and conventional patient education in the management of Helicobacter pylori eradication. We identified all patients aged between 18-75 years old and had been prescribed a 14-day course of bismuth-contained quadruple therapy for H. pylori infection in our outpatient clinics between 1 July 2019 and 31 July 2021. H. pylori infection was confirmed by any two positive outcomes of rapid urease test,13C-urea breath test (UBT) and histopathology. Patients who had H. pylori therapy history, using other therapeutic regimens or unwilling to take prescribed medications were excluded. Demographic data, treatment regimens, outcomes of therapy, adherence to therapy and adverse event were retrieved. The main indicator is eradication rate, as the secondary indicators are compliance and adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patient education | patients in experimental group were asked to join a WeChat group, which was governed by experienced gastroenterologists. Relevant knowledge of H. pylori eradication was released in the group chat irregularly. Patients in WeChat group were allowed to ask questions at any time during the whole treatment process, soon afterwards, suggestions were given. |
| OTHER | patient education | Patients in the control group received verbal education and a specifically designed printout with detailed instructions. |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2021-07-31
- Completion
- 2021-12-07
- First posted
- 2022-01-11
- Last updated
- 2022-03-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05186662. Inclusion in this directory is not an endorsement.